Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
KPC Pharmaceuticals Inc
600422KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, specialty herbal, fine Chinese, and classic prescription for bones and joint, antibiotic, immunosuppressive, and others. The company provides medicine and food, skin care, oral care, private care, and time-honored food series; and other products, such as oral medication and injections. It markets artemisinin antimalarials, generic drugs, and medical apparatus. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. The company was founded in 1951 and is based in Kunming, the People's Republic of China. Address: No.166 Keyi Road, Kunming, China, 650106
Analytics
WallStreetin tavoitehinta
171.92 CNYP/E-suhde
26.6949Osinkotuotto
–Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut 600422
Osinkoanalytiikka 600422
Osinkojen kasvu 5 vuoden aikana
–Jatkuva kasvu
–Maksusuhde 5 vuoden keskiarvo
33 %Osinkohistoria 600422
Osakkeen arvostus 600422
Talousasiat 600422
Tuloksia | 2019 | Dynamiikka |